Literature DB >> 822270

Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report.

L Furman, B M Camitta, N Jaffe, S E Sallan, J R Cassady, D Traggis, P Leavitt, D G Nathan, E Frei.   

Abstract

The development of an effective therapeutic regimen for acute lymphocytic leukemia (ALL) of childhood is described. By careful surveillance of toxicity and efficacy, positive modifications of treatment strategy were achieved without resorting to classically randomized trails. Teh resultant protocol utilizes vincristine-prednisone induction followed by asparaginase consolidation, intensive intermittent combination maintenance chemotherapy with adriamycin as a major component, and cranial radiotherapy plus intrathecal methotrexate for central nervous system prophylaxis. Preliminary analysis suggests that this regimen may result in prolonged continuous complete remission in at least 80% of children with ALL.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822270     DOI: 10.1002/mpo.2950020205

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

1.  Lymphoblast cell size and prognosis in acute lymphoblastic leukemia in childhood.

Authors:  G E Janka; S Teige-Singer; R J Haas; B M Lau
Journal:  Blut       Date:  1978-08-15

2.  Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.

Authors:  John M Goldberg; Rebecca E Scully; Stephen E Sallan; Steven E Lipshultz
Journal:  J Pediatr Hematol Oncol       Date:  2012-07       Impact factor: 1.289

3.  A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours.

Authors:  R T Penson; M V Seiden; U A Matulonis; L J Appleman; A F Fuller; A Goodman; S M Campos; J W Clark; M Roche; J P Eder
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.